Chinese General Practice ›› 2019, Vol. 22 ›› Issue (16): 1954-1959.DOI: 10.12114/j.issn.1007-9572.2019.00.286
• Monographic Research • Previous Articles Next Articles
Published:
2019-06-05
Online:
2019-06-05
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.286
[1]方圻,陈灏珠,郁知非.中国正常人血尿酸调查及其与血脂的关系[J].中华内科杂志,1983,31(22):434-438. FANG Q,CHEN H Z,YU Z F.Investigation of blood uric acid in normal Chinese people and its relationship with blood lipids[J].Chinese Journal of Internal Medicine,1983,31(22):434-438. [2]LIU R,HAN C,WU D,et al.Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014:a systematic review and meta-analysis[J].Bio Med Research International,2015:762820.DOI:10.1155/2015/762820. [3]SHIOZAWA A,SZABO S M,BOLZANI A,et al.Serum uric acid and the risk of incident and recurrent gout:a systematic review[J].The Journal of Rheumatology,2017,44(3):388-396.DOI:10.3899/jrheum.160452. [4]MCCARTY D J.Gout without hyperuricemia[J].JAMA,1994,271(4):302-303.DOI:10.1001/jama.1994.03510280064034. [5]HADLER N M,FRANCK W A,BRESS N M,et al.Acute polyarticular gout[J].The American Journal of Medicine,1974,56(5):715-719.DOI:10.1016/0002-9343(74)90639-1. [6]HALL A P,BARRY P E,DAWBER T R,et al.Epidemiology of gout and hyperuricemia.A long-term population study[J].The American Journal of Medicine,1967,42(1):27-37.DOI:10.1016/0002-9343(67)90004-6. [7]ODA E.Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population[J].Heart and Vessels,2014,29(4):496-503.DOI:10.1007/s00380-013-0386-2. [8]FORMAN J P,CHOI H,CURHAN G C.Plasma uric acid level and risk for incident hypertension among men[J].JASN,2007,18(1):287-292.DOI:10.1681/ASN.2006080865. [9]KRISHNAN E,KWOH C K,SCHUMACHER H R,et al.Hyperuricemia and incidence of hypertension among men without metabolic syndrome[J].Hypertension,2007,49(2):298-303.DOI:10.1161/01.HYP.0000254480.64564.b6. [10]TANIGUCHI Y,HAYASHI T,TSUMURA K,et al.Serum uric acid and the risk for hypertension and type 2 diabetes in Japanese men:the Osaka Health Survey[J].Journal of Hypertension,2001,19(7):1209-1215.DOI:10.1097/00004872-200107000-00005. [11]DEHGHAN A,VAN HOEK M,SIJBRANDS E J G,et al.High serum uric acid as a novel risk factor for type 2 diabetes[J].Diabetes Care,2008,31(2):361-362.DOI:10.2337/dc07-1276. [12]NISKANEN L K,LAAKSONEN D E,NYYSS?NEN K,et al.Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men:a prospective cohort study[J].Archives of Internal Medicine,2004,164(14):1546-1551.DOI:10.1001/archinte.164.14.1546. [13]ALDERMAN M H,COHEN H,MADHAVAN S,et al.Serum uric acid and cardiovascular events in successfully treated hypertensive patients[J].Hypertension,1999,34(1):144-150.DOI:10.1161/01.HYP.34.1.144. [14]FANG J,ALDERMAN M H.Serum uric acid and cardiovascular mortality the NHANES Ⅰ epidemiologic follow-up study,1971—1992.National Health and Nutrition Examination Survey[J].JAMA,2000,283(18):2404-2410.DOI:10.1001/jama.283.18.2404. [15]TALAAT K M,EL-SHEIKH A R.The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease[J].American Journal of Nephrology,2007,27(5):435-440.DOI:10.1159/000105142. [16]中华医学会内分泌学分会.高尿酸血症和痛风治疗的中国专家共识[J].中华内分泌代谢杂志,2013,29(11):913-920.DOI:10.3760/cma.j.issn.1000-6699.2013.11.001. Chinese Society of Endocrinology.Chinese expert consensus on hyperuricemia and gout treatment[J].Chinese Journal of Endocrinology and Metabolism,2013,29(11):913-920.DOI:10.3760/cma.j.issn.1000-6699.2013.11.001. [17]WALLACE S L,ROBINSON H,MASI A T,et al.Preliminary criteria for the classification of the acute arthritis of primary gout[J].Arthritis and Rheumatism,1977,20(3):895-900.DOI:10.1002/art.1780200320. [18]中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防控制指南[M].北京:人民卫生出版社,2006. [19]王吉耀.内科学[M].3版.北京:人民卫生出版社,2015. [20]ALBERTI K G,ZIMMET P Z.Definition,diagnosis and classification of diabetes mellitus and its complications.Part 1:diagnosis and classification of diabetes mellitus provisional report of a WHO consultation[J].Diabetic Medicine,1998,15(7):539-553. [21]陈灏珠.实用内科学[M].北京:人民卫生出版社,2005. [22]杜蕙,陈顺乐,王元.上海市黄浦区社区高尿酸血症与痛风流行病学调查[J].中华风湿病学杂志,1998,2(2):75-78.DOI:10.3760/j.issn.1007-7480.1998.02.005. DU H,CHEN S L,WANG Y.Epidemiological investigation of hyperuricemia and gout in Huangpu District of Shanghai[J].Chinese Journal of Rheumatology,1998,2(2):75-78.DOI:10.3760/j.issn.1007-7480.1998.02.005. [23]尹潍.老年人高尿酸血症及痛风的特点[J].中华老年医学杂志,2003,22(6):331-332.DOI:10.3760/j.issn.0254-9026.2003.06.006. YIN W.The investigation and multivariable statistical analysis of hyperuricemia in 1 500 elderly people[J].Chinese Journal of Geriatrics,2003,22(6):331-332.DOI:10.3760/j.issn.0254-9026.2003.06.006. [24]王宏儒,鲍晓荣.上海市社区老年人高尿酸血症及相关危险因素调查分析[J].中国中西医结合肾病杂志,2017,18(10):869-872.DOI:10.3969/j.issn.1009-587X.2017.10.008. WANG H R,BAO X R.Morbidity and risk factors of hyperuricemia in elderly people from a Shanghai community[J].Chinese Journal of Integrated Traditional and Western Nephrology,2017,18(10):869-872.DOI:10.3969/j.issn.1009-587X.2017.10.008. [25]吴健慧,赵楚生,周厚仕,等.饮食习惯影响高尿酸血症的回顾性分析[J].中国基层医药,2009,16(2):268-269.DOI:10.3760/cma.j.issn.1008-6706.2009.02.044. WU J H,ZHAO C S,ZHOU H S,et al.Association of dietary habits with hyperuricemia risk:a retrospective study[J].Chinese Journal of Primary Medicine and Pharmacy,2009,16(2):268-269.DOI:10.3760/cma.j.issn.1008-6706.2009.02.044. [26]MIKKELSEN W M,DODGE H J,VALKENBURG H.The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia:Tecumesh,Michigan 1959—1960[J].The American Journal of Medicine,1965,39:242-251.DOI:10.1016/0002-9343(65)90048-3. [27]WINGROVE C S,WALTON C,STEVENSON J C.The effect of menopause on serum uric acid levels in non-obese healthy women[J].Metabolism,1998,47(4):435-438.DOI:10.1016/S0026-0495(98)90056-7. [28]BENGTSSON C,TIBBLIN E.Serum uric acid levels in women.An epidemiological survey with special reference to women with high serum uric acid values[J].Acta Medica Scandinavica,1974,196(1/2):93-102.DOI:10.1111/j.0954-6820.1974.tb00974.x. [29]TAKIUE Y,HOSOYAMADA M,KIMURA M,et al.The effect of female hormones upon urate transport systems in the mouse kidney[J].Nucleosides,Nucleotides and Nucleic Acids,2011,30(2):113-119.DOI:10.1080/15257770.2010.551645. [30]YAHYAOUI R,ESTEVA I,HARO-MORA J J,et al.Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons[J].The Journal of Clinical Endocrinology and Metabolism,2008,93(6):2230-2233.DOI:10.1210/jc.2007-2467. [31]KOGA M,SAITO H,MUKAI M,et al.Factors contributing to increased serum urate in postmenopausal Japanese females[J].Climacteric,2009,12(2):146-152.DOI:10.1080/13697130802607719. [32]张文,解为慈.高三酰甘油腰围表型与高尿酸血症的相关性研究[J].安徽医学,2019,40(2):186-190.DOI:10.3969/j.issn.1000-0399.2019.02.022. ZHANG W,XIE W C.Study on the correlation between waist circumference phenotype of hypertriglyceride and hyperuricemia [J].Anhui Medical Journal,2019,40(2):186-190.DOI:10.3969/j.issn.1000-0399.2019.02.022. [33]俞婧,吴皓,李明珍,等.天津市高中生血清谷丙转氨酶升高与高尿酸血症的关系[J].中国医学创新,2014,7(3):5-8.DOI:10.3969/j.issn.1674-4985.2014.03.003. YU J,WU H,LI M Z,et al.The relationship between alanine aminotransferase and hyperuricemia among high school students in Tianjin[J].Chinese Medical Innovations,2014,7(3):5-8.DOI:10.3969/j.issn.1674-4985.2014.03.003. [34]CHEN S C C,HUANG Y F,WANG J D.Hyperferritinemia and hyperuricemia may be associated with liver function abnormality in obese adolescents[J].PLoS One,2012,7(10):e48645.DOI:10.1371/journal.pone.0048645. [35]GLANTZOUNIS G K,TSIMOYIANNIS E C,KAPPAS A M,et al.Uric acid and oxidative stress[J].Current Pharmaceutical Design,2005,11(32):4145-4151.DOI:10.2174/138161205774913255. [36]秦恳,马秀英,周婷,等.成人非酒精性脂肪肝与高尿酸血症关系的研究[J].华西医学,2012,27(2):226-229.DOI:51-1356/R.20120214.1531.046. QIN K,MA X Y,ZHOU T,et al.Research on the relationship between non-alcoholic fatty liver disease and hyperuricemia in adults [J].West China Medical Journal,2012,27(2):226-229.DOI:51-1356/R.20120214.1531.046. [37]LEHTO S,NISKANEN L,R?NNEMAA T,et al.Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus[J].Stroke,1998,29(3):635-639.DOI:10.1161/01.STR.29.3.635. [38]DAVIS N S.The cardio-vascular and renal relations and manifestations of gout[J].Journal of the American Medical Association,1897,29(6):261-262.DOI:10.1001/jama.1897.02440320005001a. [39]KOK V C,HORNG J T,WANG M N,et al.Gout as a risk factor for osteoporosis:epidemiologic evidence from a population-based longitudinal study involving 108 060 individuals[J].Osteoporosis International,2018,29(4):973-985.DOI:10.1007/s00198-018-4375-2. [40]KOSTEV K.Association between gout and osteoporosis risk in the United Kingdom[J].Osteoporosis International,2018,29(7):1685.DOI:10.1007/s00198-018-4477-x. [41]DENNISON E M,RUBIN K H,SCHWARZ P,et al.Is allopurinol use associated with an excess risk of osteoporotic fracture?A National Prescription Registry study[J].Archives of Osteoporosis,2015,10(1):36.DOI:10.1007/s11657-015-0241-4. [21]VERDECCHIA P,ANGELI F.Natural history of hypertension subtypes[J].Circulation,2005,111(9):1094.DOI:10.1161/01.CIR.0000158690.78503.5F. [22]COLAFELLA K M M,DENTON K M.Sex-specific differences in hypertension and associated cardiovascular disease[J].Nature Reviews Nephrology,2018,14(3):185-201.DOI:10.1038/nrneph.2017.189. [23]黄尧,操基玉,程自平.合肥某三甲医院2012—2014年心血管病住院患者流行病学分析[J].安徽医学,2017,38(2):144-146.DOI:10.3969/j.issn.1000-0399.2017.02.005. HUANG Y,CAO J Y,CHENG Z P.Epidemiology analysis of inpatients with cardiovascular diseases in a certain hospital of Hefei in 2012—2014[J].Anhui Medical Journal,2017,38(2):144-146.DOI:10.3969/j.issn.1000-0399.2017.02.005. [24]邹卓群,仲怀琴,李金鹆,等.上海市某院2015年体检人群H型高血压的患病率及其影响因素分析[J].安徽医学,2017,38(11):1440-1444.DOI:10.3969/j.issn.1000-0399.2017.11.020. ZOU Z Q,ZHONG H Q,LI J Y,et al.Prevalence rate of H-type hypertension and its risk factors among medical examination population in a hospital of Shanghai in 2015[J].Anhui Medical Journal,2017,38(11):1440-1444.DOI:10.3969/j.issn.1000-0399.2017.11.020. [25]RAPSOMANIKI E,TIMMIS A,GEORGE J,et al.Blood pressure and incidence of twelve cardiovascular diseases:lifetime risks,healthy life-years lost,and age-specific associations in 1.25 million people[J].Lancet,2014,383(9932):1899-1911.DOI:10.1016/S0140-6736(14)60685-1. [26]尚婕,张梅,赵振平,等.2013年中国成年人吸烟状况与多种慢性病的关联研究[J].中华流行病学杂志,2018,39(4):433-438.DOI:10.3760/cma.j.issn.0254-6450.2018.04.009. SHANG J,ZHANG M,ZHAO Z P,et al.Relations between cigarette smoking and chronic diseases of Chinese adults in 2013[J].Chinese Journal of Epidemiology,2018,39(4):433-438.DOI:10.3760/cma.j.issn.0254-6450.2018.04.009. |
[1] | YAO Yuzhong, MA Xiaojun, SONG Huan, ZHONG Yu. The Management Effect of Diabetes "1358 model" on Community Diabetes Patients Based on "Precision Management Combining General Care and Specialty Care" [J]. Chinese General Practice, 2023, 26(34): 4308-4314. |
[2] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[3] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[4] | HUANG Jinling, ZENG Zhirong. The Logic and Trend of Urban Community Health Service Policies in China [J]. Chinese General Practice, 2023, 26(34): 4239-4245. |
[5] | YANG Hui, HU Ruwei, LIU Ruqing, LU Junfeng, WU Jinglan. Relationship between Community Health Service Experience and Glycemic Control Outcomes in Patients with Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(34): 4290-4295. |
[6] | XU Jian, DAI Fangfang, PAN Wenlei, HUANG Qian, LU Ping, WANG Jianfeng, JIA Huan, YANG Yuqi, HUANG Jiaoling. Visual Analysis of Hotspots and Cutting-edge Trends of Community TCM Service Research in China in the Context of Healthy China [J]. Chinese General Practice, 2023, 26(34): 4343-4350. |
[7] | WANG Lina, GAO Pengfei, CAO Fan, GE Ying, YAN Wei, HE Daikun. Analysis of the Prevalence and Influencing Factors of Non-alcoholic Fatty Liver Disease in Different Gender Groups [J]. Chinese General Practice, 2023, 26(33): 4143-4151. |
[8] | LIU Weina, GE Haiyan, MA Jing, CAO Qinying, BAI Xingyu, CUI Shifang, QIAO Yanxia. A Study on the Relationship of Vitamin A and E Levels in Umbilical Cord Blood with Respiratory Distress Syndrome in Preterm Infants [J]. Chinese General Practice, 2023, 26(33): 4152-4158. |
[9] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[10] | YIN Zhaoxia, MAO Lidong, ZHANG Baoshuang, HUANG Yin, FENG Yang, WANG Yunfei. Spectrum of Outpatient Illnesses in Children Contracting Family Doctor Services in Shenzhen's Community Settings and Related Implications for Standardized Residency Training of General Practitioners [J]. Chinese General Practice, 2023, 26(33): 4218-4224. |
[11] | LI Jixin, QIU Linjie, REN Yan, WANG Wenru, LI Meijie, ZHANG Jin. The Correlation of Dietary Inflammatory Index with Overweight, Obesity and Abdominal Obesity: a Meta-analysis [J]. Chinese General Practice, 2023, 26(32): 4089-4097. |
[12] | JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079. |
[13] | MA Liyuan, WANG Zengwu, FAN Jing, HU Shengshou. Interpretation of Report on Cardiovascular Health and Diseases in China 2022 [J]. Chinese General Practice, 2023, 26(32): 3975-3994. |
[14] | LI Yujing, JIN Yichao, CHEN Xing, JI Mengying, DAI Huihua. Risk Factors for Endometrial Lesions Detected by Hysteroscopy in Breast Cancer Patients Taking Tamoxifen [J]. Chinese General Practice, 2023, 26(32): 4026-4030. |
[15] | ZHOU Yingda, ZHUO Shuxiong, YANG Xi, JIN Hua, YU Dehua. Implementation Status and Strategy Research on the Construction of Clinical Pathways for Diagnosis and Treatment of Medically Unexplained Disease in Community General Practice [J]. Chinese General Practice, 2023, 26(31): 3939-3944. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||